Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the optogenetics market?

The market size of optogenetics has witnessed considerable growth recently, and it is predicted to inflate further from $35.91 billion in 2024 to $41.16 billion in 2025, maintaining a compound annual growth rate (CAGR) of 14.6%. The significant growth observed in the historic period has been spurred by factors such as the increasing occurrence of neurological disorders, enhanced financing in life sciences, advancements in drug discovery and development, mapping of neural circuits, the association of optogenetics in drug screening, as well as progress in neurophotonics.

What will be the optogenetics market size in the future?

In the coming years, the optogenetics market size is anticipated to witness a swift expansion. It’s set to increase to a size of $71.95 billion by 2029, registering a compound annual growth rate (CAGR) of 15.0%. The projected growth during this period can be linked to factors like therapeutic applications, clinical trials and translation, the adaptation into non-neuronal cells, the use of optogenetics in brain-machine interfaces, and the development of new light-sensitive proteins. The forecast period will also see major trends such as the progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the use of optogenetics in drug discovery and development, spreading into non-neural cell forms, and combination with other imaging technologies.

Get your optogenetics market report here!

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What main drivers are fueling expansion in the optogenetics market?

The optogenetics market is predicted to expand as a result of the increasing incidence of Parkinson’s disease and epilepsy globally. Parkinson’s disease, a progressive brain disorder, causes motor problems including shaking, slow movement, stiffness and imbalance, along with other problems like cognitive decline, mental health problems, sleep disturbances, pain and sensory problems. Epilepsy, another brain disorder, leads to seizures. Optogenetic therapy employs proteins that react to certain light wavelengths to treat Parkinson’s disease. These proteins, generated through gene therapy techniques, either activate or deactivate when exposed to specific light types, which can help to restore normal functioning in the brain of patients with Parkinson’s disease. For example, The Parkinson’s Foundation, a U.S.-based organization committed to enhancing the quality of life for those affected by Parkinson’s disease, reported in December 2022 a significant increase in the annual Parkinson’s disease diagnoses, with nearly 90,000 cases, up from the earlier estimate of 60,000. Furthermore, the number of individuals with PD in the U.S. is projected to rise to 1.2 million by 2030 from 930,000 in 2020. Consequently, the escalating numbers of Parkinson’s disease and epilepsy cases worldwide are propelling the optogenetics market.

What key areas define the segmentation of the global optogenetics market?

The optogenetics market covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Who are the dominant players expanding their reach in the optogenetics market?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

How are evolving market trends shaping optogenetics Strategies?

The emergence of pioneering systems is the central trend gaining traction in the optogenetics market. The main players in the optogenetics market are creating innovative tools and systems equipped with advanced technologies to maintain their market standing. For example, in June 2022, Bruker Corporation, an American optogenetics tool production company, introduced the NeuraLight 3D Ultra, an improved 3D holographic stimulation for an optogenetics module. This is designed to support leading-edge neuroscience and optogenetics research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra provides state-of-the-art 3D holographic photostimulation, specifically tailored for comprehensive functional research on neural networks and brain computation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009

Which regions are emerging as leaders in the optogenetics market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: